Early phase 1Enrolling by invitation
Truway Diagnostic Tools in Primary Care (TruDxPC)
Evaluation of Truway Health-Sourced Portable Diagnostic Devices for Early Detection of Chronic Conditions in Outpatient Primary Care Settings: A Prospective Interventional Study
- Sponsor
- Truway Health, Inc. (Industry)
- Enrollment
- 200 planned
- Conditions
- Chronic Disease; Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight; Hypertension; Cardiovascular Disease Acute; Hyperlipidemia; Chronic Kidney Disease (CKD), Stages 3-4 Exercise Tolerance / Functional Capacity Vascular Health / Arterial Stiffness Fatigue in CKD; Peripheral Artery Disease; Metabolic Syndrome; Prediabetes
- Interventions
- Truway Portable Ultrasound Device; Truway Blood Glucose Monitor; Standard Oral Hypoglycemic Agent
- Ages
- children, adults, older adults
- Registry
- NCT07209527
Full record on ClinicalTrials.gov
From the registry
This study evaluates the effectiveness of Truway Health-sourced portable diagnostic devices, including ultrasound and blood glucose monitors, in early detection of chronic conditions in outpatient primary care settings. Conducted as a prospective interventional trial, 200 participants will be assigned to use these devices versus standard care over a 6-month period. The primary outcome is improved diagnostic accuracy and patient outcomes. The study, led by Truway Health, Inc., aims to enhance accessible healthcare solutions starting at a New York site, with potential expansion to Miami.
Primary outcomes
- Rate of Early Detection of Chronic Conditions
- Improvement in Glycemic Control
History
Primary completion expected
Last registry update
Registered
Started